LOS ANGELES (Sept. 30, 2014) – The ALS Program at Cedars-Sinai has become the first in Southern California to be named an ALS Association Certified Treatment Center of Excellence – a distinction that ...
SEATTLE, Dec. 10, 2019 /PRNewswire/ -- The Answer ALS research program, a consortium of medical research centers, technology companies like Avanade, and 1,000 ALS patients, has completed phase one ...
LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
SAN JOSE, Calif., June 29, 2026 /PRNewswire/ -- WideTrial is pleased to share that the Expanded Access Program it launched in 2025, Scalable Expanded Access with Analysis of Neurofilament and other ...
This pivotal investment represents a meaningful commitment from the provincial government to address the urgent and evolving needs of people affected by ALS. The program will deliver vital services ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results